Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Total 13F shares
-
33,888,820
-
Share change
-
+2,923,259
-
Total reported value
-
$739,146,337
-
Price per share
-
$21.81
-
Number of holders
-
97
-
Value change
-
+$60,776,521
-
Number of buys
-
64
-
Number of sells
-
20
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q1 2021
As of 31 Mar 2021,
Avidity Biosciences, Inc. - Common Stock (RNA) was held by
97 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,888,820 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, FMR LLC, BlackRock Inc., Cormorant Asset Management, LP, EcoR1 Capital, LLC, FEDERATED HERMES, INC., PRICE T ROWE ASSOCIATES INC /MD/, ALETHEA CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and VANGUARD GROUP INC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.